Genetic features of B-cell chronic lymphocytic leukemia.
about
Prediction and preliminary validation of oncogene regulation by miRNAsThe RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERADIonizing radiation and chronic lymphocytic leukemia.Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaChronic lymphocytic leukaemia--the haematologic basis for diagnosis and treatment.Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse.ATM mutations in sporadic lymphoid tumours.Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.FISH Analysis for del6q21 and del17p13 in B-cell Chronic Lymphocytic Leukemia in Iranians.Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the tradeMicroenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion.AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.A genome scan of 18 families with chronic lymphocytic leukaemia.p53 protein expression in chronic lymphocytic leukemia.
P2860
Q21262991-1A56519B-D73A-4FD0-9E5D-5F8FA8B9D929Q24297892-371F049E-BD9C-4186-A363-6C8D52AEBF3EQ24534890-74964EFA-2CBB-4179-A05F-18A7DF5D10A9Q26851166-85E2EED1-13F0-46FD-A6CF-E935F9B2F3DEQ33343670-D3294D71-78C8-405A-AD2E-7B596268B40EQ33620305-1306E539-89F5-48FA-A6F3-067408C1E02DQ33800449-D9EC91AF-4FEE-425C-983F-A3A598183EBEQ34325953-FA70E096-E978-4AE2-9D8D-6C01769E982EQ34980360-C54E45F5-B657-45AF-9D94-C83B27B85DA9Q35790006-05CEF18B-8991-45CF-9EEA-D0E595EC311DQ36837347-ACF504A5-6924-4DE8-8992-23F28821AC11Q36839266-E06A4A5D-F166-4EF5-B1DD-8D6C44FB7BA3Q36867755-239000B9-232C-41DB-BA0F-BF0E1177C092Q38550810-0E7A62A0-091F-4E17-BFF8-1801CCF3DF86Q40502956-45358DCF-AB85-4F59-868C-494EB575DB02Q43246073-7AC40B4C-8864-4A45-B7F5-84C7A9465E76Q44605532-103F1173-6650-4D92-BA49-40D1CBF16EF6Q44619783-5ED4B9A5-BDBB-478D-A5F0-2E7915D9BAB4Q46727262-592AC3D0-B35C-4342-9364-2D6099F2A2B7Q47861335-0E7931AF-30ED-4872-BDE0-3461E6BD9E77Q54330797-81AF8868-2DBC-48BF-99E4-E7B81FC7BD45
P2860
Genetic features of B-cell chronic lymphocytic leukemia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genetic features of B-cell chronic lymphocytic leukemia.
@ast
Genetic features of B-cell chronic lymphocytic leukemia.
@en
type
label
Genetic features of B-cell chronic lymphocytic leukemia.
@ast
Genetic features of B-cell chronic lymphocytic leukemia.
@en
prefLabel
Genetic features of B-cell chronic lymphocytic leukemia.
@ast
Genetic features of B-cell chronic lymphocytic leukemia.
@en
P2093
P2860
P1476
Genetic features of B-cell chronic lymphocytic leukemia.
@en
P2093
Stilgenbauer S
P2860
P356
10.1046/J.1468-0734.2000.00003.X
P577
2000-03-01T00:00:00Z